DNA Script, Moderna to develop on-demand vaccines, therapeutics

By The Science Advisory Board staff writers

DNA Script and Moderna have announced a partnership to develop on-demand vaccines and therapeutics as part of the U.S. Defense Advanced Research Projects Agency's (DARPA) Nucleic Acids On-Demand World-Wide (NOW) program.

The initiative will make use of DNA Script's enzymatic synthesis platform, which generates high-fidelity nucleic acids without the use of hazardous chemical solvents, the company said. Moderna will use these acids to produce messenger RNA therapeutics and vaccines. DNA Script will receive up to $5 million from DARPA.


Copyright © 2021 scienceboard.net
 

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a Scienceboard.net password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?